Task: Answer the multiple choice question.
Question: Which drug has a -0.803\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Cl)cc1
b: c1ccc(CCN2CN(CCCN3CCOCC3)c3nc4ccccc4n3C2)cc1
Answer: a. Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Cl)cc1
Cc1cn(C(=O)c2ccccc2)c(=S)n1-c1ccc(Cl)cc1
[3-(4-chlorophenyl)-4-methyl-2-sulfanylideneimidazol-1-yl]-phenylmethanone